8:07 27/08/2014 Trading Volume Shifts: Image Sensing Systems, Inc.(NASDAQ:ISNS), Arena ...
Trading Volume Shifts: Image Sensing Systems, Inc.(NASDAQ:ISNS), Arena ...
GSPInsider - 5 hours ago
Arena Pharmaceuticals, Inc.(NASDAQ:ARNA) gained seven cents to finish the day at a closing price of $4.25, a 1.67% increase in value from the previous closing price.

15:26 26/08/2014 Why Need to Watch : OncoMed Pharmaceuticals (NASDAQ:OMED), Arena ...
Why Need to Watch : OncoMed Pharmaceuticals (NASDAQ:OMED), Arena ...
Crazy Joys - 22 hours ago
OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED) was a big mover last session, as its shares rose over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session.

14:52 26/08/2014 Notable Analyst Actions: Merrimack Pharmaceuticals Inc (NASDAQ:MACK ...
Notable Analyst Actions: Merrimack Pharmaceuticals Inc (NASDAQ:MACK ...
Markets Insider - 22 hours ago
Anakytsts expect Merrimack Pharmaceuticals Inc (NASDAQ:MACK) to find a marketing partner for MM-398 outside the U.S. in the near-term.

13:22 26/08/2014 Stock Runners: Arena Pharmaceuticals (NASDAQ:ARNA), AT&T, Inc. (NYSE:T ...
Stock Runners: Arena Pharmaceuticals (NASDAQ:ARNA), AT&T, Inc. (NYSE:T ...
Tech News - Aug 26, 2014
On 1 AUG Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) issued its quarterly earnings data on Friday. The company reported $0.03 earnings per share for the quarter, beating the analysts' consensus estimate of ($0.11) by $0.14.

18:36 25/08/2014 Advertising And The Belviq Re-Launch
Advertising And The Belviq Re-Launch
Seeking Alpha (registration) - Aug 25, 2014
July of 2014 marked the "re-launch" of the anti-obesity drug Belviq from Arena Pharmaceuticals (NASDAQ:ARNA) and marketing partner Eisai (OTCPK:ESALY). Belviq had its initial launch in June of ... Needless to say, Arena stock suffered because sales ...

14:52 25/08/2014 Belviq Sales Rise 2%
Belviq Sales Rise 2%
Seeking Alpha (registration) - Aug 25, 2014
Sales of the anti-obesity pill Belviq from Arena Pharmaceuticals (NASDAQ:ARNA) continued to buck the seasonality factor by bringing in a 2% increase in week over week sales according to industry tracker IMS Health.

13:22 19/08/2014 Concerns on Biotech Stocks- Arena Pharmaceuticals, Inc. (NASDAQ:ARNA ...
Concerns on Biotech Stocks- Arena Pharmaceuticals, Inc. (NASDAQ:ARNA ...
eMarketsDaily - Aug 19, 2014
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) [Trend Analysis] recently delivered Belviq sales of $3.5M (including $0.4 million from the 15-day free trial voucher redemption).

7:55 12/08/2014 Are These Biopharmaceutical Companies Weak Investment Options? Arena ...
Are These Biopharmaceutical Companies Weak Investment Options? Arena ...
NIS - Aug 12, 2014
Arena Pharmaceuticals, Inc.(NASDAQ:ARNA) maintained its value during yesterday's trading, finishing the day at its previous closing price of $4.39.

15:17 04/08/2014 Arena Pharmaceuticals Falls on Wider-than-Expected Q2 Loss
Arena Pharmaceuticals Falls on Wider-than-Expected Q2 Loss
Zacks.com - Aug 4, 2014
Arena Pharmaceuticals, Inc. (ARNA - Snapshot Report) fell approximately 3.7% after the company reported a net loss (excluding one-time items) of 12 cents per share in the second quarter of 2014 wider than the Zacks Consensus Estimate of loss of 11 cents.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Dips As Loss Goes Beyond ... - FinancialsTrend
Belviq Scripts Flat For Arena (ARNA) - Seeking Alpha (registration)

0:48 02/08/2014 Arena Pharmaceuticals Posts Increased Revenue In Second Quarter
Arena Pharmaceuticals Posts Increased Revenue In Second Quarter
Bidness Etc - Aug 1, 2014
Arena Pharmaceuticals, Inc. (ARNA) reported financial results for the second quarter of its fiscal year 2014 (2QFY14) before the market opened today.
Arena Pharmaceuticals Provides Corporate Update and Reports Second ... - MarketWatch